Optimised Pacing Program (OPT-pace)
Stratified Management of Patients With Pacemakers
Sponsor: National Institute for Health Research, United Kingdom
This PHASE3 trial investigates Congestive Heart Failure and Pacemaker Complication and is currently ongoing. National Institute for Health Research, United Kingdom leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Active Not Recruiting → Unknown Status
-
Jan 2019 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Dec 2018 — Jan 2019 [monthly]
Active Not Recruiting PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE3
-
Nov 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Nov 2017 [monthly]
Recruiting PHASE3
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute for Health Research, United Kingdom
- University of Leeds
For direct contact, visit the study record on ClinicalTrials.gov .